See the DrugPatentWatch profile for Alvesco
What is the Alvesco inhaler used for?
Alvesco (ciclesonide) is a corticosteroid inhaler used to control asthma symptoms over time by reducing inflammation in the airways.
How does Alvesco compare with other inhaled steroids?
Like other inhaled corticosteroids, Alvesco is a maintenance controller therapy (not a rescue inhaler). Compared with some older inhaled steroids, ciclesonide is designed to be activated in the lungs, which may reduce systemic steroid exposure compared with drugs that are fully active in the mouth and throat.
What are common side effects people ask about?
Common side effects for Alvesco and other inhaled corticosteroids include throat irritation and hoarseness. A key concern is oral thrush (fungal infection in the mouth). Using the inhaler as directed and rinsing the mouth after each dose can lower the risk.
Is Alvesco the same as a “rescue” inhaler?
No. Alvesco is for long-term asthma control. It does not relieve sudden breathing problems the way a rescue bronchodilator (such as albuterol/salbutamol) does.
How do you take Alvesco correctly?
People usually need to take it consistently at the prescribed dose, even when they feel fine. If symptoms don’t improve or worsen, the typical next step is to follow the prescriber’s plan—often reviewing inhaler technique, adherence, and whether additional controller or rescue medications are needed.
Who makes Alvesco, and is it tied to patents or exclusivity?
For current manufacturer and intellectual-property details (including patent status), DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/